(3R,4S,5R,6R)-4-[(2R,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Term ID

CHEBI:154611

Synonyms

alpha-D-xylo-pentopyranosyl-(1->3)-alpha-D-xylo-pentopyranosyl-(1->3)-D-gluco-hexopyranose
WURCS=2.0/2,3,2/[a2122h-1x_1-5][a212h-1a_1-5]/1-2-2/a3-b1_b3-c1
Xyl(a1-3)Xyl(a1-3)Glc

Definition

References

GlyGen:G86535WT
GlyTouCan:G86535WT

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3R,4S,5R,6R)-4-[(2R,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype where environments contain (3R,4S,5R,6R)-4-[(2R,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype modified by environments containing (3R,4S,5R,6R)-4-[(2R,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype affecting (3R,4S,5R,6R)-4-[(2R,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Human Disease Model